AFCR announces the winners of the 2024 BRACE Award Venture Competition

Asian Fund for Cancer Research (AFCR) shared a post on LinkedIn:

“AFCR is pleased to announce the winners of the 2024 BRACE Award Venture Competition: the First Prize goes to Concarlo Therapeutics, led by Founder and CEO Stacy Blain, Ph.D., and the Second Prize goes to Orphagen Pharmaceuticals, led by its Founder and CEO Scott Thacher, Ph.D.

For more information on why these incredible organizations were chosen visit the link.

AFCR’s BRACE Award Venture Competition is designed to support and accelerate oncology innovations on their path toward commercialization, aiming to improve outcomes for patients affected by cancer globally.”

Source: Asian Fund for Cancer Research/LinkedIn